D2/D3 receptor agonist ropinirole protects dopaminergic cell line against rotenone-induced apoptosis through inhibition of caspase- and JNK-dependent pathways. (Q40017852)

From Wikidata

Jump to navigation Jump to search

scientific article published on 31 January 2008

Language	Label	Description	Also known as
English	D2/D3 receptor agonist ropinirole protects dopaminergic cell line against rotenone-induced apoptosis through inhibition of caspase- and JNK-dependent pathways.	scientific article published on 31 January 2008

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18242171%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

D2/D3 receptor agonist ropinirole protects dopaminergic cell line against rotenone-induced apoptosis through inhibition of caspase- and JNK-dependent pathways (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18242171%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

1 reference

based on heuristic

inferred from title

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18242171%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

author name string

Xiaojie Zhang

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18242171%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Dehua Yang

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18242171%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Yunlan Du

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18242171%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Liang Li

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18242171%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Xuping Li

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18242171%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Ming Ming

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18242171%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Weidong Le

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18242171%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

language of work or name

0 references

publication date

31 January 2008

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18242171%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18242171%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

582

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18242171%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18242171%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

603-610

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18242171%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Neuroprotective therapy in Parkinson disease.

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2008.01.028

21 January 2018

Apoptosis in Parkinson's disease: signals for neuronal degradation

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2008.01.028

21 January 2018

Rotenone destroys dopaminergic neurons and induces parkinsonian symptoms in rats

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2008.01.028

21 January 2018

Chronic systemic pesticide exposure reproduces features of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2008.01.028

21 January 2018

Rotenone-induced apoptosis is mediated by p38 and JNK MAP kinases in human dopaminergic SH-SY5Y cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2008.01.028

21 January 2018

Activation of c-Jun N-terminal protein kinase is a common mechanism underlying paraquat- and rotenone-induced dopaminergic cell apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2008.01.028

21 January 2018

Apoptotic signaling in dopamine-induced cell death: the role of oxidative stress, p38 mitogen-activated protein kinase, cytochrome c and caspases

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2008.01.028

21 January 2018

Signal transduction by the JNK group of MAP kinases

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2008.01.028

21 January 2018

Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2008.01.028

21 January 2018

Inhibition of the p44/42 MAP kinase pathway protects hippocampal neurons in a cell-culture model of seizure activity

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2008.01.028

21 January 2018

MEK and ERK protect hypoxic cortical neurons via phosphorylation of Bad.

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2008.01.028

21 January 2018

Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2008.01.028

21 January 2018

Rotenone induces apoptosis via activation of bad in human dopaminergic SH-SY5Y cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2008.01.028

21 January 2018

Biochemical pathways of caspase activation during apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2008.01.028

21 January 2018

Dopamine D3 receptor agonists for protection and repair in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2008.01.028

21 January 2018

Low dose pramipexole is neuroprotective in the MPTP mouse model of Parkinson's disease, and downregulates the dopamine transporter via the D3 receptor

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2008.01.028

21 January 2018

Biological effects of pramipexole on dopaminergic neuron-associated genes: relevance to neuroprotection.

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2008.01.028

21 January 2018

Gene and protein expression profiles of anti- and pro-apoptotic actions of dopamine, R-apomorphine, green tea polyphenol (-)-epigallocatechine-3-gallate, and melatonin

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2008.01.028

21 January 2018

Slower progression of Parkinson's disease with ropinirole versus levodopa: The REAL-PET study

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2008.01.028

21 January 2018

Dopamine D3 receptor-preferring agonists induce neurotrophic effects on mesencephalic dopamine neurons

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2008.01.028

21 January 2018

S32504, a novel naphtoxazine agonist at dopamine D3/D2 receptors: II. Actions in rodent, primate, and cellular models of antiparkinsonian activity in comparison to ropinirole

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2008.01.028

21 January 2018

Neuroprotective effects of the novel D3/D2 receptor agonist and antiparkinson agent, S32504, in vitro against 1-methyl-4-phenylpyridinium (MPP+) and in vivo against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): a comparison to ropinirole.

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2008.01.028

21 January 2018

The dopamine D2 receptor: new surprises from an old friend

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2008.01.028

21 January 2018

Decoding dopamine signaling

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2008.01.028

21 January 2018

Agonist-specific transactivation of phosphoinositide 3-kinase signaling pathway mediated by the dopamine D2 receptor

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2008.01.028

21 January 2018

A novel role for phosphatidylinositol 3-kinase beta in signaling from G protein-coupled receptors to Akt.

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2008.01.028

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40017852&oldid=1478061490"